Showing results (1341-1350 of 1,512) with videos related to

Sort By:
Pageof 152
Surgical Endoscopy|December 12, 2018
The treatment indication and optimal management of fluid collection after laparoscopic distal pancreatectomyKi Byung Song, Jaewoo Kwon, Young-Joo Lee, et al.
JTO Clinical and Research Reports|October 10, 2025
Durvalumab With or Without Tremelimumab in Combination With Chemoradiotherapy in Patients With Limited-Stage SCLC: Results from the Phase 1 CLOVER StudyByoung Chul Cho, Myung-Ju Ahn, Makoto Nishio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 22, 2017
ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC)Byoung Chul Cho, Dong-Wan Kim, Alessandra Bearz, et al.
Neuroscience Bulletin|February 20, 2020
Association of Polygenic Risk Score with Age at Onset and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in a Chinese CohortWei-Wei Li, Zhen Wang, Dong-Yu Fan, et al.
Cancer Immunology, Immunotherapy : CII|November 24, 2020
Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancyChanghee Park, Kyeonghun Jeong, Joon-Hyeong Park, et al.
Pharmacogenetics and Genomics|July 17, 2014
Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessmentSoJeong Yi, Hyungmi An, Howard Lee, et al.
JTO Clinical and Research Reports|October 1, 2025
Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5Anas Gazzah, Charles Ricordel, Antoine Italiano, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplificationSai-Hong Ignatius Ou, Eunice L Kwak, Christina Siwak-Tapp, et al.
Gut and Liver|October 7, 2021
Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate on Computed TomographySung Woo Ko, Tae Hyeon Kim, Tae Jun Song, et al.
Japanese Journal of Clinical Oncology|November 26, 2010
Increasing nodal ratio is a poor prognostic factor for survival in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant chemotherapy: a retrospective studyJin-Soo Kim, Min-A Kim, Do-Youn Oh, et al.
Pageof 152